3D打印材料有新突破 6只业绩增长概念股市盈率不到30倍

Core Insights - A research team from the University of Virginia has developed a new type of 3D printing material that is compatible with the human immune system, potentially advancing medical technologies such as artificial organ transplantation and drug delivery [1] - The breakthrough has been published in the latest issue of the journal Advanced Materials, indicating significant progress in the field [1] - The new material may be combined with other materials to create 3D printed products with varying chemical compositions, expanding its applications [1] Industry Summary - The new material demonstrates higher conductivity and stretchability at room temperature compared to existing solid polymer electrolytes, highlighting its potential as a high-performance solid electrolyte in advanced battery technologies [1] - The research team plans to continue exploring the material's applications in solid-state battery technology [1] - In the A-share market, over 40 companies are involved in the 3D printing industry, with 24 companies showing year-on-year profit growth in the first three quarters of this year [1] - Notable companies with significant profit growth include Inno Laser, Chuangjiang New Material, Aobo Zhongguang-UW, Bolite, and Yinhui Technology [1] - Among the 24 companies with profit growth, 6 have a rolling price-to-earnings ratio below 30, including Lizhong Group, Yizhiming, Yaxia Shares, Yongli Shares, Aidi Te, and Changjiang Materials [1]